Find disease awareness content and relevant supporting materials

By Nancy LapidAug 5 (Reuters) - We also report on another promising experimental non-opioid pain drug for use following surgery.AI HELPS FIND UNTAPPED HEALTH PREDICTORS IN

We also report on new insights into the skin-discoloring disorder vitiligo that may someday lead to corrective treatments.

We also report on an experimental diagnostic approach that can detect tuberculosis exposure and infection at an earlier stage than current methods.

Management of asymptomatic lower limb PAD and intermittent claudication (ESVS) summarises the 2024 ESVS clinical practice recommendations for diagnosis and treatment of peripheral arterial disease. The guideline highlights evidence-based use of exercise therapy, preventive pharmacotherapy, and contemporary endovascular options to support shared clinical decision making.

2021 ACR guideline for the treatment of rheumatoid arthritis provides evidence-based recommendations for the pharmacologic management of RA. The guideline covers DMARD selection, glucocorticoid use and treatment considerations for patients with significant comorbidities, supporting shared clinical decision-making.

Recommendations for rheumatoid arthritis management (APLAR 2024 update) presents updated evidence-based guidance for rheumatoid arthritis management across the Asia-Pacific region. The recommendations address disease activity monitoring, csDMARDs, targeted therapies, infection prevention strategies, and treatment considerations during pregnancy.

This guideline provides seven evidence-based recommendations to support biologic selection in adults with severe asthma. It highlights how biomarkers, asthma endotype, exacerbation burden, oral corticosteroid use, lung function, quality of life and comorbidities may influence treatment decisions, while noting the need for comparative effectiveness data.

From diagnostic delay to treatment integration

We also report a new and improved way of monitoring Parkinson's disease medication levels.